Aldosterone upregulates vascular endothelial growth factor expression in mouse cortical collecting duct epithelial cells through classic mineralocorticoid receptor

Life Sciences

Volumn 81, Issue 7, 2007, Pages 570-576

  Lai, Lingyun ^a   Pen, Ai ^a,b   Hu, Yeshi ^a   Ma, Ji ^a   Chen, Jin ^a   Hao, Chuan Ming ^a,c   Gu, Yong ^a   Lin, Shanyan ^a  

^a FUDAN UNIVERSITY   (China)

^b TONGJI UNIVERSITY   (China)

^c VANDERBILT UNIVERSITY   (United States)

Author keywords

Aldosterone; Epithelial cells; Vascular endothelial growth factor

Indexed keywords

ALDOSTERONE; MESSENGER RNA; MINERALOCORTICOID RECEPTOR; SPIRONOLACTONE; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN 120; VASCULOTROPIN 164;

ANIMAL CELL; ARTERY LIGATION; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMORAL ARTERY; HEMODYNAMICS; IMMUNOFLUORESCENCE; INCUBATION TIME; KIDNEY COLLECTING TUBULE; KIDNEY FIBROSIS; KIDNEY TUBULE EPITHELIUM; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; UPREGULATION; WESTERN BLOTTING;

ALDOSTERONE; ANIMALS; BLOTTING, WESTERN; CELL LINE; CYTOSOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIAL CELLS; FLUORESCENT ANTIBODY TECHNIQUE; KIDNEY CORTEX; KIDNEY TUBULES, COLLECTING; MICE; MICROSCOPY, CONFOCAL; RECEPTORS, MINERALOCORTICOID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

RATTUS;

EID: 34547659799     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2007.06.025     Document Type: Article

References (23)

1. Alvarez Arroyo M.V., Suzuki Y., Yague S., Lorz C., Jimenez S., Soto C., Barat A., Belda E., Gonzalez-Pacheco F.R., Deudero J.J., Castilla M.A., Egido J., Ortiz A., and Caramelo C. Role of endogenous vascular endothelial growth factor in tubular cell protection against acute cyclosporine toxicity. Transplantation 74 11 (2002) 1618-1624
2. Bernini G.P., Moretti A., Bonadio A.G., Menicagli M., Viacava P., Naccarato A.G., Iacconi P., Miccoli P., and Salvetti A. Angiogenesis in human normal and pathologic adrenal cortex. The Journal of Clinical Endocrinology and Metabolism 87 11 (2001) 4961-4965
3. Brown N.J., Nakamura S., and Ma L. Aldosterone modulates plasminogen activator inhibitor-1 and glomerulosclerosis in vivo. Kidney International 58 3 (2000) 1219-1227
4. Choi Y.J., Chakraborty S., and Nguyen V. Peritubular capillary loss is associated with chronic tubulointerstitial injury in human kidney: altered expression of vascular endothelial growth factor. Human Pathology 31 12 (2000) 1491-1497
5. Epstein M. Aldosterone as a mediator of progressive renal dysfunction: evolving perspectives. Internal Medicine 40 7 (2001) 573-583
6. Feria I., Pichardo I., Juarez P., Ramirez V., Gonzalez M.A., Uribe N., Garcia-Torres R., Lopez-Casillas F., Gamba G., and Bobadilla N.A. Therapeutic benefit of spironolactone in experimental chronic cyclosporine A nephrotoxicity. Kidney International 63 1 (2003) 43-52
7. Ferrara N., Gerber H.P., and LeCouter J. The biology of VEGF and its receptors. Nature Medicine 9 6 (2003) 669-676
8. Hostetter T.H., and Ibrahim H.N. Aldosterone in chronic kidney and cardiac disease. Journal of the American Society of Nephrology 14 9 (2003) 2395-2401
9. Ibrahim H.N., and Hostetter T.H. Aldosterone in renal disease. Current Opinion in Nephrology and Hypertension 12 2 (2003) 159-164
10. Juknevicius I., Segal Y., Kren S., Lee R., and Hostetter T.H. Effect of aldosterone on renal transforming growth factor-beta. American Journal of Physiology. Renal Physiology 286 6 (2004) F1059-F1062
11. Kang D.H., Hughes J., Mazzali M., Schreiner G.F., and Johnson R.J. Impaired angiogenesis in the remnant kidney model (I): potential role of vascular endothelial growth factor and thrombospondin-1. Journal of the American Society of Nephrology 12 7 (2001) 1434-1447
12. Lai L., Chen J., Hao C.M., Lin S.Y., and Gu Y. Aldosterone promotes fibronectin production through a Smad2-dependent TGF-beta1 pathway in mesangial cells. Biochemical and Biophysical Research Communication 348 1 (2006) 70-75
13. Michel F., Ambroisine M.L., Duriez M., Delcayre C., Levy B.I., and Silvestre J.S. Aldosterone enhances ischemia-induced neovascularization through angiotensin II-dependent pathway. Circulation 109 16 (2004) 1933-1937
14. Moeckel G.W., Zhang L., Fogo A.B., Hao C.M., Pozzi A., and Breyer M.D. COX2 activity promotes organic osmolyte accumulation and adaptation of renal medullary interstitial cells to hypertonic stress. The Journal of Biological Chemistry 278 21 (2003) 19352-19357
15. Nancym J.B. Aldosterone and end-organ damage. Current Opinion in Nephrology and Hypertension 14 3 (2005) 235-241
16. Neufeld G., Cohen T., Gengrinovitch S., and Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. The FASEB Journal 13 1 (1999) 9-22
17. Ngarmukos C., and Grekin R.J. Nontraditional aspects of aldosterone physiology. American Journal of Physiology. Endocrinology and Metabolism 281 6 (2001) E1122-E1127
18. Schrijvers B.F., Flyvbjerg A., and De Vriese A.S. The role of vascular endothelial growth factor (VEGF) in renal pathophysiology. Kidney International 65 6 (2004) 2003-2017
19. Silvestre J.S., Heymes C., Oubenaissa A., Robert V., Aupetit-Faisant B., Carayon A., Swynghedauw B., and Delcayre C. Activation of cardiac aldosterone production in rat myocardial infarction: effect of angiotensin II receptor blockade and role in cardiac fibrosis. Circulation 99 20 (1999) 2694-2701
20. Tortora G., Damiano V., Bianco C., Baldassarre G., Bianco A.R., Lanfrancone L., Pellicci P.G., and Ciardiello F. The R1 subunit of protein kinase A (PKA) binds to Grb2 and allows PKA interaction with the activated EGF-receptor. Oncogene 14 8 (1997) 923-928
21. Wakelin S.J., Marson L., Howie S.E., Garden J., Lamb J.R., and Forsythe J.L. The role of vascular endothelial growth factor in the kidney in health and disease. Nephron Physiology 98 3 (2004) 73-79
22. Xue C., and Siragy H.M. Local renal aldosterone system and its regulation by salt, diabetes, and angiotensin II type 1 receptor. Hypertension 46 3 (2005) 584-590
23. Zhou X., Ono H., Ono Y., and Frohlich E.D. Aldosterone antagonism ameliorates proteinuria and nephrosclerosis independent of glomerular dynamics in l-NAME/SHR model. American Journal of Nephrology 24 2 (2004) 242-249